Biosynex Ownership

ALBIO Stock  EUR 2.77  0.11  3.82%   
The market capitalization of Biosynex is €121.6 Million. Biosynex retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with substantial debt, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.
Some institutional investors establish a significant position in stocks such as Biosynex in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Biosynex, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biosynex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Biosynex Stock Ownership Analysis

About 58.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.77. Some equities with similar Price to Book (P/B) outperform the market in the long run. Biosynex recorded earning per share (EPS) of 6.37. The entity last dividend was issued on the 16th of May 2022. The firm had 697:694 split on the 5th of July 2017. Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France. BIOSYNEX is traded on Paris Stock Exchange in France. For more info on Biosynex please contact Larry Abensur at 33 3 88 78 78 87 or go to https://www.biosynex.com.

Biosynex Outstanding Bonds

Biosynex issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biosynex uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biosynex bonds can be classified according to their maturity, which is the date when Biosynex has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biosynex Stock Analysis

When running Biosynex's price analysis, check to measure Biosynex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosynex is operating at the current time. Most of Biosynex's value examination focuses on studying past and present price action to predict the probability of Biosynex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosynex's price. Additionally, you may evaluate how the addition of Biosynex to your portfolios can decrease your overall portfolio volatility.